BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
April 30, 2026
Company
Cartesian Therapeutics, Inc. (RNAC)
Other upcoming events for RNAC
Phase 2 Readout
Phase 2 Readout: descartes-08
Dec 31, 2026
Phase 3 Readout
Phase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Genera
Sep 30, 2027
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
RNAC Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — RNAC Earnings Report | BioSniper